文献速递消化内镜消化道肿瘤与早癌

基线结肠镜发现与筛查队列10年结局的关联

Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
PubMed 文献 · Gastroenterology · 2019-07-31

该研究基于3121名无症状退伍军人筛查结肠镜队列,纳入1915名至少接受1次监测结肠镜者,随访10年。基线结直肠癌和进展期腺瘤者的10年进展期肿瘤累积发生率最高,分别为43.7%和21.9%;基线1-2个小腺瘤者风险低,与无肿瘤者无显著差异。

要点

  • 基线结直肠癌者10年进展期肿瘤累积发生率为43.7%(95%CI 13.0%-74.4%)。
  • 基线进展期腺瘤者10年累积发生率为21.9%(95%CI 15.7%-28.1%)。
  • 基线1-2个小腺瘤者后续进展期肿瘤风险与无肿瘤者无显著差异(OR 0.96)。

核心结论

  • 基线筛查结肠镜发现与10年内进展期肿瘤相关,基线仅1-2个小腺瘤者10年进展期肿瘤风险低。

研究设计与样本

  • 基于退伍军人事务部合作研究项目3121名50-75岁无症状退伍军人,1994-1997年在13个医疗中心接受筛查结肠镜并随访10年或至死亡,纳入1915名至少接受1次监测结肠镜者。

主要发现

  • 10年随访期间所有基线结肠镜组中共146人发现至少1次进展期肿瘤。
  • 10年进展期肿瘤累积发生率在基线结直肠癌组为43.7%(95%CI 13.0%-74.4%),基线进展期腺瘤组为21.9%(95%CI 15.7%-28.1%)。
  • 基线1-2个小腺瘤(<1cm,无绒毛组织学或高级别异型增生)组10年累积发生率为6.3%(95%CI 4.1%-8.5%),无肿瘤组为4.1%(95%CI 2.7%-5.4%),log-rank P = .10。
  • 调整既往监测后,基线1或2个小腺瘤者每次后续检查进展期肿瘤风险与无基线肿瘤者无显著差异(OR 0.96;95%CI 0.67-1.41)。

临床怎么用

  • 基线筛查结肠镜发现可关联10年内进展期肿瘤风险;基线仅1-2个小腺瘤者10年进展期肿瘤风险低,可考虑替代监测策略。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Few studies have evaluated long-term outcomes of ongoing colonoscopic screening and surveillance in a screening population. We aimed to determine the 10-year risk for advanced neoplasia (defined as adenomas ≥10mm, adenomas with villous histology or high-grade dysplasia, or colorectal cancer [CRC]) and assessed whether baseline colonoscopy findings were associated with long-term outcomes. METHODS: We collected data from the Department of Veterans Affairs Cooperative Studies Program Study on 3121 asymptomatic veterans (50-75 years old) who underwent a screening colonoscopy from 1994 through 1997 at 13 medical centers and were then followed for 10 years or until death. We included 1915 subjects with at least 1 surveillance colonoscopy and estimated cumulative incidence of advanced neoplasia by Kaplan-Meier curves. We then fit a longitudinal joint model to estimate risk of advanced neoplasia at each subsequent examination after baseline, adjusting for multiple colonoscopies within individuals. RESULTS: Through 10 years of follow-up, there were 146 individuals among all baseline colonoscopy groups found to have at least 1 incident advanced neoplasia. The cumulative 10-year incidence of advanced neoplasia was highest among those with baseline CRC (43.7%; 95% CI 13.0%-74.4%), followed by those with baseline advanced adenoma (AA) (21.9%; 95% CI 15.7-28.1). The cumulative 10-year incidence of advanced neoplasia was 6.3% (95% CI 4.1%-8.5%) and 4.1% (95% CI 2.7%-5.4%) for baseline 1 to 2 small adenomas (<1cm, and without villous histology or high-grade dysplasia) and no neoplasia, respectively (log-rank P = .10). After adjusting for prior surveillance, the risk of advanced neoplasia at each subsequent examination was not significantly increased in veterans with 1 or 2 small adenomas at baseline (odds ratio 0.96; 95% CI 0.67-1.41) compared with veterans with no baseline neoplasia. CONCLUSIONS: Baseline screening colonoscopy findings associate with advanced neoplasia within 10 years. Individuals with only 1 or 2 small adenomas at baseline have a low risk of advanced neoplasia over 10 years. Alternative surveillance strategies, could be considered for these individuals.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Lieberman D, Sullivan BA, Hauser ER, et al. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. Gastroenterology. 2019. PMID: 31376388. doi:10.1053/j.gastro.2019.07.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。